A detailed history of Fmr LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Fmr LLC holds 85 shares of INMB stock, worth $453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Previous 585 85.47%
Holding current value
$453
Previous $6,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.15 - $11.84 $3,575 - $5,920
-500 Reduced 85.47%
85 $0
Q1 2024

May 13, 2024

BUY
$10.53 - $14.01 $5,265 - $7,005
500 Added 588.24%
585 $6,000
Q2 2023

Aug 11, 2023

SELL
$6.5 - $10.09 $45 - $70
-7 Reduced 7.61%
85 $0
Q1 2023

May 11, 2023

BUY
$6.01 - $10.18 $498 - $844
83 Added 922.22%
92 $0
Q4 2022

Feb 13, 2023

BUY
$6.13 - $7.96 $55 - $71
9 New
9 $0

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $95.7M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.